Prices delayed by at least 15 minutes | Print
BIOTEST AG VZ O.N. (BIO3)
VORZUGSAKTIEN O.ST. O.N.Open
€29.2
Previous close
€28.9
Trade high
€29.3
Volume
361
Year high
€33.20
Year low
€22.80
Dividend yield
-
Market capitalisation
€1.16 bn
P/E ratio
8.97
ISIN
DE0005227235
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.